Good mood surrounds Depakote® for bipolar disorders

&

Low-dose valproate semisodium [divalproex sodium, Depakote®; Abbott] may be effective in stabilising symptoms in patients with cyclothymia or bipolar II disorder, according to the findings of a study presented at the 96th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics [ San Diego, US; March 1995 ]. Furthermore, for the first time, researchers have noted a relationship between illness severity and the dosage of valproate semisodium required for symptom stabilisation. The implications of these findings for the treatment of bipolar disorders were discussed.